LivaNova (LIVN) EBIT Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 170.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170.11% |
| Dec 31, 2025 | 45.02% |
| Sep 30, 2025 | 34.06% |
| Jun 30, 2025 | 19.49% |
| Mar 31, 2025 | 72.30% |
| Dec 31, 2024 | 14.36% |
| Sep 30, 2024 | 29.44% |
| Jun 30, 2024 | 45.93% |
| Mar 31, 2024 | 69.28% |
| Dec 31, 2023 | 29.30% |
| Sep 30, 2023 | 37.34% |
| Jun 30, 2023 | 44.83% |
| Mar 31, 2023 | -59.15% |
| Dec 31, 2022 | 28.00% |
| Sep 30, 2022 | -92.41% |
| Jun 30, 2022 | 45.23% |
| Mar 31, 2022 | 34.95% |
| Dec 31, 2021 | 27.84% |
| Sep 30, 2021 | 69.30% |
| Jun 30, 2021 | -54.36% |
| Mar 31, 2021 | -34.90% |
| Dec 31, 2020 | -147.42% |
| Sep 30, 2020 | -31.07% |
| Jun 30, 2020 | -37.56% |
| Mar 31, 2020 | -26.61% |
| Dec 31, 2019 | -113.11% |
| Sep 30, 2019 | -5.34% |
| Jun 30, 2019 | -47.27% |
| Mar 31, 2019 | -31.81% |
| Dec 31, 2017 | 52.22% |